pentobarbital will minimize the extent or impact of ethotoin by impacting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Keep track of.
pentobarbital will minimize the level or result of abemaciclib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of abemaciclib with sturdy CYP3A4 inducers lessens plasma concentration of abemaciclib and its metabolites.
pentobarbital will minimize the extent or influence of alfuzosin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.
pentobarbital will lessen the extent or effect of finasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Mysterious.
pentobarbital will minimize the extent or influence of copyright topical by affecting hepatic enzyme CYP2B6 metabolism. Slight/Importance Unfamiliar.
Reserve concomitant prescribing of these drugs in individuals for whom other treatment choices are insufficient. Restrict dosages and durations into the minimal demanded. Keep an eye on intently for indications of respiratory depression and sedation.
pentobarbital will reduce the extent or outcome of estrogens conjugated synthetic more info by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will decrease the extent or effect of montelukast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Mysterious.
Contraindicated (1)pentobarbital will decrease the extent or impact of doravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
buprenorphine transdermal and pentobarbital the two maximize sedation. Prevent or Use Alternate Drug. Restrict use to patients for whom different procedure choices are inadequate
pentobarbital will lessen the extent or outcome of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will decrease the level or result of cariprazine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the extent or effect of lumacaftor/ivacaftor by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will lessen the extent or influence of zaleplon by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Mysterious.